I think there are two possibilities, much like I said last time
1. Mesoblast recieves a third CRL along with a request for a new trial.
2. Mesoblast receives a conditional approval for children. That is along the lines of the Canadian regulator, where they have a limited time eg two years to conduct a better controlled trial and if Mesoblast doesn't do it the approval is withdrawn.
I would expect that Mesoblast will get some revenues from that through Dr Kurtzberg it's but unlikely enough to cover expenses and costs, so they will continue to run at a loss. The time will expire without a result and approval will eventually be withdrawn. SI will squeal and write letters requesting new meetings and parade more anecdotal stories but this time the FDA will stand firm.
- Forums
- ASX - By Stock
- MSB
- MESO Nasdaq update
MESO Nasdaq update, page-5670
-
- There are more pages in this discussion • 258 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
0.010(0.72%) |
Mkt cap ! $1.581B |
Open | High | Low | Value | Volume |
$1.39 | $1.41 | $1.38 | $588.5K | 423.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 62898 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 3786 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 52911 | 1.390 |
8 | 42709 | 1.385 |
11 | 80349 | 1.380 |
15 | 110861 | 1.375 |
11 | 111828 | 1.370 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 418 | 1 |
1.400 | 27947 | 6 |
1.405 | 56532 | 9 |
1.410 | 129872 | 13 |
1.415 | 109239 | 6 |
Last trade - 10.33am 11/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online